RBC Life Sciences, Inc.

2301 Crown Court - Irving, Texas 75038


Press Release      For Further Information:

For Immediate Release

     Steve Brown, CFO
     Tel: 972-893-4000

RBC Life Sciences Reports Annual Results

Irving, Texas (March 5, 2007) – RBC Life Sciences, Inc. (RBCL OTC:BB) today reported a 12% increase in net sales to $21,697,000 and a 15% increase in earnings before income taxes to $714,000 in the year ended December 31, 2006 compared to net sales of $19,361,000 and earnings before income taxes of $619,000 in the previous year. Net earnings in 2006 were $436,000, or $0.02 per share, compared with net earnings in 2005 of $592,000, or $0.03 per share.

Net earnings declined in 2006 because of the $251,000 increase in our provision for income taxes to $278,000 in 2006 from $27,000 in the previous year. The tax provision in 2006 increased because the Company used up its net operating loss carryforwards, as determined for financial reporting purposes, in 2005.

Clinton Howard, CEO, stated, “The growth in earnings before income taxes was driven by improved operating margins and strong sales increases in both of our operating segments: nutritional products and MPM medical products. Growth in sales of nutritional products was generated by a 34% increase in sales to our international licensees.

“Orders from international licensees for which a deposit has been made, and finished products, which are fully paid but held pending receipt of shipping instructions, represent our backlog and have not been recorded as sales. This backlog of orders increased 39% to $3,374,000 at the end of 2006 compared to a backlog of $2,436,000 at the end of 2005.”

The Company manufactures and markets nutritional supplements, skincare products, and nanoscale compounds including its largest selling product, Microhydrin® Plus™, an antioxidant that scavenges cell-damaging free radicals. RBC products are sold worldwide through independent distributors and licensees in 17 countries.

Our wholly owned subsidiary, MPM Medical Inc., markets a line of oncology products to treat certain skin conditions caused by cancer treatments, and other wound care products used in hospitals, nursing homes, and cancer clinics.

The statements above, other than statements of historical facts, may be forward-looking. Actual events will be dependent upon a number of factors and risks including but not limited to changes in plans by the Company’s management, delays or problems in production, changes in the regulatory process, changes in market trends, and a number of other factors and risks described from time to time in the Company’s filings with the Securities and Exchange Commission.

The following information was filed by Rbc Life Sciences, Inc. (RBCL) on Wednesday, March 7, 2007 as an 8K 2.02 statement, which is an earnings press release pertaining to results of operations and financial condition. It may be helpful to assess the quality of management by comparing the information in the press release to the information in the accompanying 10-K Annual Report statement of earnings and operation as management may choose to highlight particular information in the press release.

View differences made from one year to another to evaluate Rbc Life Sciences, Inc.'s financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 10-K Annual Report to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Rbc Life Sciences, Inc..


Never Miss A New SEC Filing Again

Real-Time SEC Filing Notifications
Screenshot taken from Gmail for a new 10-K Annual Report
Last10K.com Member Feature

Receive an e-mail as soon as a company files an Annual Report, Quarterly Report or has new 8-K corporate news.


We Highlighted This SEC Filing For You

SEC Filing Sentiment Analysis - Bullish, Bearish, Neutral
Screenshot taken from Wynn's 2018 10-K Annual Report
Last10K.com Member Feature

Read positive and negative remarks made by management in their entirety without having to find them in a 10-K/Q.


Widen Your SEC Filing Reading Experience

Increased Reading Area for SEC Filings
Screenshot taken from Adobe Inc.'s 10-Q Quarterly Report
Last10K.com Member Feature

Remove data columns and navigations in order to see much more filing content and tables in one view


Uncover Actionable Information Inside SEC Filings

SEC Filing Disclosures
Screenshot taken from Lumber Liquidators 10-K Annual Report
Last10K.com Member Feature

Read both hidden opportunities and early signs of potential problems without having to find them in a 10-K/Q


Adobe PDF, Microsoft Word and Excel Downloads

Download Annual and Quarterly Reports as PDF, Word and Excel Documents
Screenshots of actual 10-K and 10-Q SEC Filings in PDF, Word and Excel formats
Last10K.com Member Feature

Export Annual and Quarterly Reports to Adobe PDF, Microsoft Word and Excel for offline viewing, annotations and analysis


FREE Financial Statements

Download Annual and Quarterly Reports as PDF, Word and Excel Documents
Screenshot of actual balance sheet from company 10-K Annual Report
Last10K.com Member Feature

Get one-click access to balance sheets, income, operations and cash flow statements without having to find them in Annual and Quarterly Reports

Continue for FREE

Intrinsic Value Calculator

Intrinsic Value Calculator
Screenshot of intrinsic value for AT&T (2019)
Last10K.com Member Feature

Our Intrinsic Value calculator estimates what an entire company is worth using up to 10 years of financial ratios to determine if a stock is overvalued or not


Financial Stability Report

Financial Stability Report
Screenshot of financial stability report for Coco-Cola (2019)
Last10K.com Member Feature

Our Financial Stability reports uses up to 10 years of financial ratios to determine the health of a company's EPS, Dividends, Book Value, Return on Equity, Current Ratio and Debt-to-Equity


Get a Better Picture of a Company's Performance

Financial Ratios
Available Financial Ratios
Last10K.com Member Feature

See how over 70 Growth, Profitability and Financial Ratios perform over 10 Years


Log in with your credentials


Forgot your details?

Create Account